For use with Sofia 2 and Sofia Analyzers - FDA Emergency Use Authorization.
The Sofia SARS Antigen Fluorescent Immunoassay (FIA) uses advanced immunofluorescence-based lateral flow technology in a sandwich design for qualitative detection of nucleocapsid protein from SARS-CoV-2. The Sofia SARS Antigen FIA, with the Sofia 2 and Sofia analyzers, provides automated and objective results in 15 minutes, allowing for testing of patients suspected of COVID-19/2019-nCoV in near-patient testing environments. Positive and negative controls included in kit. CLIA Waived. 25 tests/kit, 12 kits/cs (300 tests per case). Priced per case.